Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer the multiple leiomyoma consortium

Ian P M Tomlinson, N. Afrina Alam, Andrew J. Rowan, Ella Barclay, Emma E M Jaeger, David Kelsell, Irene Leigh, Patricia Gorman, Hanan Lamlum, Shamima Rahman, Rebecca R. Roylance, Simon Olpin, Stephen Bevan, Karen Barker, Nicholas Hearle, Richard S. Houlston, Maija Ht Kiuru, Rainer Lehtonen, Auli Karhu, Susa VilkkiPäivi Laiho, Carita Eklund, Outi Vierimaa, Kristiina Aittomäki, Marja Hietala, Pertti Sistonen, Anders Paetau, Reijo Salovaara, Riitta Herva, Virpi Launonen, Lauri A. Aaltonen

Research output: Contribution to journalArticle

980 Citations (Scopus)

Abstract

Uterine leiomyomata (fibroids) are common and clinically important tumors, but little is known about their etiology and pathogenesis1-3. We previously mapped a gene that predisposes to multiple fibroids, cutaneous leiomyomata and renal cell carcinoma to chromosome 1q42.3-q43 (refs 4-6). Here we show, through a combination of mapping critical recombinants, identifying individuals with germline mutations and screening known and predicted transcripts, that this gene encodes fumarate hydratase, an enzyme of the tricarboxylic acid cycle. Leiomyomatosis-associated mutations are predicted to result in absent or truncated protein, or substitutions or deletions of highly conserved amino acids. Activity of fumarate hydratase is reduced in lymphoblastoid cells from individuals with leiomyomatosis. This enzyme acts as a tumor suppressor in familial leiomyomata, and its measured activity is very low or absent in tumors from individuals with leiomyomatosis. Mutations in FH also occur in the recessive condition fumarate hydratase deficiency−11, and some parents of people with this condition are susceptible to leiomyomata. Thus, heterozygous and homozygous or compound heterozygous mutants have very different clinical phenotypes. Our results provide clues to the pathogenesis of fibroids and emphasize the importance of mutations of housekeeping and mitochondrial proteins in the pathogenesis of common types of tumor12-14.

Original languageEnglish (US)
Pages (from-to)406-410
Number of pages5
JournalNature Genetics
Volume30
Issue number4
DOIs
StatePublished - 2002
Externally publishedYes

Fingerprint

Germ-Line Mutation
Leiomyoma
Renal Cell Carcinoma
Fumarate Hydratase
Leiomyomatosis
Skin
Mutation
Housekeeping
Neoplasms
Citric Acid Cycle
Mitochondrial Proteins
Enzymes
Genes
Chromosomes
Phenotype
Amino Acids
Proteins

ASJC Scopus subject areas

  • Genetics

Cite this

Tomlinson, I. P. M., Alam, N. A., Rowan, A. J., Barclay, E., Jaeger, E. E. M., Kelsell, D., ... Aaltonen, L. A. (2002). Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer the multiple leiomyoma consortium. Nature Genetics, 30(4), 406-410. https://doi.org/10.1038/ng849

Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer the multiple leiomyoma consortium. / Tomlinson, Ian P M; Alam, N. Afrina; Rowan, Andrew J.; Barclay, Ella; Jaeger, Emma E M; Kelsell, David; Leigh, Irene; Gorman, Patricia; Lamlum, Hanan; Rahman, Shamima; Roylance, Rebecca R.; Olpin, Simon; Bevan, Stephen; Barker, Karen; Hearle, Nicholas; Houlston, Richard S.; Kiuru, Maija Ht; Lehtonen, Rainer; Karhu, Auli; Vilkki, Susa; Laiho, Päivi; Eklund, Carita; Vierimaa, Outi; Aittomäki, Kristiina; Hietala, Marja; Sistonen, Pertti; Paetau, Anders; Salovaara, Reijo; Herva, Riitta; Launonen, Virpi; Aaltonen, Lauri A.

In: Nature Genetics, Vol. 30, No. 4, 2002, p. 406-410.

Research output: Contribution to journalArticle

Tomlinson, IPM, Alam, NA, Rowan, AJ, Barclay, E, Jaeger, EEM, Kelsell, D, Leigh, I, Gorman, P, Lamlum, H, Rahman, S, Roylance, RR, Olpin, S, Bevan, S, Barker, K, Hearle, N, Houlston, RS, Kiuru, MH, Lehtonen, R, Karhu, A, Vilkki, S, Laiho, P, Eklund, C, Vierimaa, O, Aittomäki, K, Hietala, M, Sistonen, P, Paetau, A, Salovaara, R, Herva, R, Launonen, V & Aaltonen, LA 2002, 'Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer the multiple leiomyoma consortium', Nature Genetics, vol. 30, no. 4, pp. 406-410. https://doi.org/10.1038/ng849
Tomlinson, Ian P M ; Alam, N. Afrina ; Rowan, Andrew J. ; Barclay, Ella ; Jaeger, Emma E M ; Kelsell, David ; Leigh, Irene ; Gorman, Patricia ; Lamlum, Hanan ; Rahman, Shamima ; Roylance, Rebecca R. ; Olpin, Simon ; Bevan, Stephen ; Barker, Karen ; Hearle, Nicholas ; Houlston, Richard S. ; Kiuru, Maija Ht ; Lehtonen, Rainer ; Karhu, Auli ; Vilkki, Susa ; Laiho, Päivi ; Eklund, Carita ; Vierimaa, Outi ; Aittomäki, Kristiina ; Hietala, Marja ; Sistonen, Pertti ; Paetau, Anders ; Salovaara, Reijo ; Herva, Riitta ; Launonen, Virpi ; Aaltonen, Lauri A. / Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer the multiple leiomyoma consortium. In: Nature Genetics. 2002 ; Vol. 30, No. 4. pp. 406-410.
@article{d98e62b74f344426bb94e35f41f6aa6e,
title = "Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer the multiple leiomyoma consortium",
abstract = "Uterine leiomyomata (fibroids) are common and clinically important tumors, but little is known about their etiology and pathogenesis1-3. We previously mapped a gene that predisposes to multiple fibroids, cutaneous leiomyomata and renal cell carcinoma to chromosome 1q42.3-q43 (refs 4-6). Here we show, through a combination of mapping critical recombinants, identifying individuals with germline mutations and screening known and predicted transcripts, that this gene encodes fumarate hydratase, an enzyme of the tricarboxylic acid cycle. Leiomyomatosis-associated mutations are predicted to result in absent or truncated protein, or substitutions or deletions of highly conserved amino acids. Activity of fumarate hydratase is reduced in lymphoblastoid cells from individuals with leiomyomatosis. This enzyme acts as a tumor suppressor in familial leiomyomata, and its measured activity is very low or absent in tumors from individuals with leiomyomatosis. Mutations in FH also occur in the recessive condition fumarate hydratase deficiency−11, and some parents of people with this condition are susceptible to leiomyomata. Thus, heterozygous and homozygous or compound heterozygous mutants have very different clinical phenotypes. Our results provide clues to the pathogenesis of fibroids and emphasize the importance of mutations of housekeeping and mitochondrial proteins in the pathogenesis of common types of tumor12-14.",
author = "Tomlinson, {Ian P M} and Alam, {N. Afrina} and Rowan, {Andrew J.} and Ella Barclay and Jaeger, {Emma E M} and David Kelsell and Irene Leigh and Patricia Gorman and Hanan Lamlum and Shamima Rahman and Roylance, {Rebecca R.} and Simon Olpin and Stephen Bevan and Karen Barker and Nicholas Hearle and Houlston, {Richard S.} and Kiuru, {Maija Ht} and Rainer Lehtonen and Auli Karhu and Susa Vilkki and P{\"a}ivi Laiho and Carita Eklund and Outi Vierimaa and Kristiina Aittom{\"a}ki and Marja Hietala and Pertti Sistonen and Anders Paetau and Reijo Salovaara and Riitta Herva and Virpi Launonen and Aaltonen, {Lauri A.}",
year = "2002",
doi = "10.1038/ng849",
language = "English (US)",
volume = "30",
pages = "406--410",
journal = "Nature Genetics",
issn = "1061-4036",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer the multiple leiomyoma consortium

AU - Tomlinson, Ian P M

AU - Alam, N. Afrina

AU - Rowan, Andrew J.

AU - Barclay, Ella

AU - Jaeger, Emma E M

AU - Kelsell, David

AU - Leigh, Irene

AU - Gorman, Patricia

AU - Lamlum, Hanan

AU - Rahman, Shamima

AU - Roylance, Rebecca R.

AU - Olpin, Simon

AU - Bevan, Stephen

AU - Barker, Karen

AU - Hearle, Nicholas

AU - Houlston, Richard S.

AU - Kiuru, Maija Ht

AU - Lehtonen, Rainer

AU - Karhu, Auli

AU - Vilkki, Susa

AU - Laiho, Päivi

AU - Eklund, Carita

AU - Vierimaa, Outi

AU - Aittomäki, Kristiina

AU - Hietala, Marja

AU - Sistonen, Pertti

AU - Paetau, Anders

AU - Salovaara, Reijo

AU - Herva, Riitta

AU - Launonen, Virpi

AU - Aaltonen, Lauri A.

PY - 2002

Y1 - 2002

N2 - Uterine leiomyomata (fibroids) are common and clinically important tumors, but little is known about their etiology and pathogenesis1-3. We previously mapped a gene that predisposes to multiple fibroids, cutaneous leiomyomata and renal cell carcinoma to chromosome 1q42.3-q43 (refs 4-6). Here we show, through a combination of mapping critical recombinants, identifying individuals with germline mutations and screening known and predicted transcripts, that this gene encodes fumarate hydratase, an enzyme of the tricarboxylic acid cycle. Leiomyomatosis-associated mutations are predicted to result in absent or truncated protein, or substitutions or deletions of highly conserved amino acids. Activity of fumarate hydratase is reduced in lymphoblastoid cells from individuals with leiomyomatosis. This enzyme acts as a tumor suppressor in familial leiomyomata, and its measured activity is very low or absent in tumors from individuals with leiomyomatosis. Mutations in FH also occur in the recessive condition fumarate hydratase deficiency−11, and some parents of people with this condition are susceptible to leiomyomata. Thus, heterozygous and homozygous or compound heterozygous mutants have very different clinical phenotypes. Our results provide clues to the pathogenesis of fibroids and emphasize the importance of mutations of housekeeping and mitochondrial proteins in the pathogenesis of common types of tumor12-14.

AB - Uterine leiomyomata (fibroids) are common and clinically important tumors, but little is known about their etiology and pathogenesis1-3. We previously mapped a gene that predisposes to multiple fibroids, cutaneous leiomyomata and renal cell carcinoma to chromosome 1q42.3-q43 (refs 4-6). Here we show, through a combination of mapping critical recombinants, identifying individuals with germline mutations and screening known and predicted transcripts, that this gene encodes fumarate hydratase, an enzyme of the tricarboxylic acid cycle. Leiomyomatosis-associated mutations are predicted to result in absent or truncated protein, or substitutions or deletions of highly conserved amino acids. Activity of fumarate hydratase is reduced in lymphoblastoid cells from individuals with leiomyomatosis. This enzyme acts as a tumor suppressor in familial leiomyomata, and its measured activity is very low or absent in tumors from individuals with leiomyomatosis. Mutations in FH also occur in the recessive condition fumarate hydratase deficiency−11, and some parents of people with this condition are susceptible to leiomyomata. Thus, heterozygous and homozygous or compound heterozygous mutants have very different clinical phenotypes. Our results provide clues to the pathogenesis of fibroids and emphasize the importance of mutations of housekeeping and mitochondrial proteins in the pathogenesis of common types of tumor12-14.

UR - http://www.scopus.com/inward/record.url?scp=18544365990&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18544365990&partnerID=8YFLogxK

U2 - 10.1038/ng849

DO - 10.1038/ng849

M3 - Article

C2 - 11865300

AN - SCOPUS:18544365990

VL - 30

SP - 406

EP - 410

JO - Nature Genetics

JF - Nature Genetics

SN - 1061-4036

IS - 4

ER -